The Lee Company Bags TTP Ventus

The company said that TTP Ventus’ products complement its existing portfolio in the same industries.

Katie Hobbins, Managing Editor

January 31, 2023

1 Min Read
MaA (Nastassia Samal_iStock) (1).jpg
Nastassia Samal / iStock via Getty Images

The Lee Company recently announced the acquisition of TTP Ventus Limited from TTP Group, an inventor and manufacturer of silent, compact micropumps and pump modules. In the press release announcing the deal, The Lee Company said that TTP Ventus’ products complement its existing range of miniature fluid control components used across the same industries.

“TTP Ventus brings exciting new technology to The Lee Company, enhancing our offering in the strategically important life science and medical markets,” said Bill Lee, president and CEO of The Lee Company. “The fit with our existing product lines is strong, and we expect our global force of sales engineers to accelerate Ventus’ growth. The Lee Company’s unique capabilities in miniaturization and engineering keep our company at the forefront of fluid flow technology and the addition of Ventus is the latest advancement of our technologies. Our customers will now have even greater performance range and precision control of pressure and flow conditions in both liquid and pneumatic applications.”

TTP Ventus has been renamed LEE Ventus and is the eleventh production group for The Lee Company and the fourth member of its Electro Fluidic Systems (EFS) division. The company will continue operations near Cambridge, United Kingdom, becoming The Lee Company’s first international production unit.  

“We’re delighted with this successful outcome for TTP Ventus as it enters an exciting new phase in its growth,” said James McCrone, head of business operations, TTP Group. “Under TTP Group’s incubation, the team have transformed an innovative technology into an exciting new product and a successful business. The Lee Company’s established leadership in precision fluidic control and their global sales reach makes them the ideal acquisition partner.”

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like